Stockreport

MediWound Announces Peer-Reviewed Paper of a Case Series Report of Basal Cell Carcinoma Published in the Open Dermatology Journal

MediWound Ltd. - Ordinary Shares  (MDWD) 
Last mediwound ltd. - ordinary shares earnings: 2/25 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.mediwound.com/press-releases
PDF Findings Provide Preliminary Proof-of-Concept Phase I/II Clinical Study in Basal Cell Carcinoma Scheduled to Begin in Second Quarter 2021, with Data Expected [Read more]